Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men

Roger S. Blumenthal, Alan W. Heldman, Jeffrey A. Brinker, Jon R. Resar, Vicki J. Coombs, Sean T. Gloth, Gary Gerstenblith, Steven E. Reis

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Estrogen therapy is associated with a 50% reduction in the clinical manifestations of coronary artery disease in postmenopausal women. Attenuation of coronary vasomotor dysfunction may contribute to estrogen's cardioprotective effects. We hypothesized that conjugated estrogens, which contain several vasoactive estrogenic compounds, may favorably influence the vasomotor response to acetylcholine in men. Twenty men, 56 ± 5 years of age, referred for clinically indicated coronary angiography, participated in this study. Acetylcholine-induced changes in coronary flow were measured by quantitative coronary angiography and intracoronary Doppler ultrasonography before and 15 minutes after intravenous administration of conjugated estrogens (0.625 mg) in 12 men and placebo in 8 men. Initial acetylcholine infusion resulted in no significant increase in coronary blood flow. However, 15 minutes after estrogen administration repeat acetylcholine infusion caused a mean 32% increase in coronary blood flow from 41 ± 5 to 54 ± 8 ml/min (p = 0.02). Acetylcholine-induced change in flow after estrogen was significantly different from that before estrogen (p = 0.03). Placebo administration did not affect acetylcholine-induced changes in coronary flow. Thus, intravenous conjugated estrogens favorably modulate acetylcholine- induced changes in coronary hemodynamics in men. This suggests that novel nonfeminizing estrogenic compounds may have anti-ischemic effects in men.

Original languageEnglish
Pages (from-to)1021-1024
Number of pages4
JournalAmerican Journal of Cardiology
Volume80
Issue number8
DOIs
StatePublished - Oct 15 1997
Externally publishedYes

Fingerprint

Conjugated (USP) Estrogens
Acetylcholine
Estrogens
Coronary Angiography
Placebos
Doppler Ultrasonography
Intravenous Administration
Coronary Artery Disease
Hemodynamics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Blumenthal, R. S., Heldman, A. W., Brinker, J. A., Resar, J. R., Coombs, V. J., Gloth, S. T., ... Reis, S. E. (1997). Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. American Journal of Cardiology, 80(8), 1021-1024. https://doi.org/10.1016/S0002-9149(97)00596-1

Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. / Blumenthal, Roger S.; Heldman, Alan W.; Brinker, Jeffrey A.; Resar, Jon R.; Coombs, Vicki J.; Gloth, Sean T.; Gerstenblith, Gary; Reis, Steven E.

In: American Journal of Cardiology, Vol. 80, No. 8, 15.10.1997, p. 1021-1024.

Research output: Contribution to journalArticle

Blumenthal, RS, Heldman, AW, Brinker, JA, Resar, JR, Coombs, VJ, Gloth, ST, Gerstenblith, G & Reis, SE 1997, 'Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men', American Journal of Cardiology, vol. 80, no. 8, pp. 1021-1024. https://doi.org/10.1016/S0002-9149(97)00596-1
Blumenthal, Roger S. ; Heldman, Alan W. ; Brinker, Jeffrey A. ; Resar, Jon R. ; Coombs, Vicki J. ; Gloth, Sean T. ; Gerstenblith, Gary ; Reis, Steven E. / Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. In: American Journal of Cardiology. 1997 ; Vol. 80, No. 8. pp. 1021-1024.
@article{72d6a5ffc7c042268e28be4d813af44d,
title = "Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men",
abstract = "Estrogen therapy is associated with a 50{\%} reduction in the clinical manifestations of coronary artery disease in postmenopausal women. Attenuation of coronary vasomotor dysfunction may contribute to estrogen's cardioprotective effects. We hypothesized that conjugated estrogens, which contain several vasoactive estrogenic compounds, may favorably influence the vasomotor response to acetylcholine in men. Twenty men, 56 ± 5 years of age, referred for clinically indicated coronary angiography, participated in this study. Acetylcholine-induced changes in coronary flow were measured by quantitative coronary angiography and intracoronary Doppler ultrasonography before and 15 minutes after intravenous administration of conjugated estrogens (0.625 mg) in 12 men and placebo in 8 men. Initial acetylcholine infusion resulted in no significant increase in coronary blood flow. However, 15 minutes after estrogen administration repeat acetylcholine infusion caused a mean 32{\%} increase in coronary blood flow from 41 ± 5 to 54 ± 8 ml/min (p = 0.02). Acetylcholine-induced change in flow after estrogen was significantly different from that before estrogen (p = 0.03). Placebo administration did not affect acetylcholine-induced changes in coronary flow. Thus, intravenous conjugated estrogens favorably modulate acetylcholine- induced changes in coronary hemodynamics in men. This suggests that novel nonfeminizing estrogenic compounds may have anti-ischemic effects in men.",
author = "Blumenthal, {Roger S.} and Heldman, {Alan W.} and Brinker, {Jeffrey A.} and Resar, {Jon R.} and Coombs, {Vicki J.} and Gloth, {Sean T.} and Gary Gerstenblith and Reis, {Steven E.}",
year = "1997",
month = "10",
day = "15",
doi = "10.1016/S0002-9149(97)00596-1",
language = "English",
volume = "80",
pages = "1021--1024",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men

AU - Blumenthal, Roger S.

AU - Heldman, Alan W.

AU - Brinker, Jeffrey A.

AU - Resar, Jon R.

AU - Coombs, Vicki J.

AU - Gloth, Sean T.

AU - Gerstenblith, Gary

AU - Reis, Steven E.

PY - 1997/10/15

Y1 - 1997/10/15

N2 - Estrogen therapy is associated with a 50% reduction in the clinical manifestations of coronary artery disease in postmenopausal women. Attenuation of coronary vasomotor dysfunction may contribute to estrogen's cardioprotective effects. We hypothesized that conjugated estrogens, which contain several vasoactive estrogenic compounds, may favorably influence the vasomotor response to acetylcholine in men. Twenty men, 56 ± 5 years of age, referred for clinically indicated coronary angiography, participated in this study. Acetylcholine-induced changes in coronary flow were measured by quantitative coronary angiography and intracoronary Doppler ultrasonography before and 15 minutes after intravenous administration of conjugated estrogens (0.625 mg) in 12 men and placebo in 8 men. Initial acetylcholine infusion resulted in no significant increase in coronary blood flow. However, 15 minutes after estrogen administration repeat acetylcholine infusion caused a mean 32% increase in coronary blood flow from 41 ± 5 to 54 ± 8 ml/min (p = 0.02). Acetylcholine-induced change in flow after estrogen was significantly different from that before estrogen (p = 0.03). Placebo administration did not affect acetylcholine-induced changes in coronary flow. Thus, intravenous conjugated estrogens favorably modulate acetylcholine- induced changes in coronary hemodynamics in men. This suggests that novel nonfeminizing estrogenic compounds may have anti-ischemic effects in men.

AB - Estrogen therapy is associated with a 50% reduction in the clinical manifestations of coronary artery disease in postmenopausal women. Attenuation of coronary vasomotor dysfunction may contribute to estrogen's cardioprotective effects. We hypothesized that conjugated estrogens, which contain several vasoactive estrogenic compounds, may favorably influence the vasomotor response to acetylcholine in men. Twenty men, 56 ± 5 years of age, referred for clinically indicated coronary angiography, participated in this study. Acetylcholine-induced changes in coronary flow were measured by quantitative coronary angiography and intracoronary Doppler ultrasonography before and 15 minutes after intravenous administration of conjugated estrogens (0.625 mg) in 12 men and placebo in 8 men. Initial acetylcholine infusion resulted in no significant increase in coronary blood flow. However, 15 minutes after estrogen administration repeat acetylcholine infusion caused a mean 32% increase in coronary blood flow from 41 ± 5 to 54 ± 8 ml/min (p = 0.02). Acetylcholine-induced change in flow after estrogen was significantly different from that before estrogen (p = 0.03). Placebo administration did not affect acetylcholine-induced changes in coronary flow. Thus, intravenous conjugated estrogens favorably modulate acetylcholine- induced changes in coronary hemodynamics in men. This suggests that novel nonfeminizing estrogenic compounds may have anti-ischemic effects in men.

UR - http://www.scopus.com/inward/record.url?scp=0030704707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030704707&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(97)00596-1

DO - 10.1016/S0002-9149(97)00596-1

M3 - Article

VL - 80

SP - 1021

EP - 1024

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -